R
Regina Max
Researcher at Heidelberg University
Publications - 52
Citations - 1908
Regina Max is an academic researcher from Heidelberg University. The author has contributed to research in topics: Uveitis & Medicine. The author has an hindex of 20, co-authored 51 publications receiving 1737 citations. Previous affiliations of Regina Max include University Hospital Heidelberg.
Papers
More filters
Journal ArticleDOI
Uveitis Subtypes in a German Interdisciplinary Uveitis Center—Analysis of 1916 Patients
Eva Jakob,Mirjam S. Reuland,Friederike Mackensen,Nadine Harsch,Monika Fleckenstein,Hanns Martin Lorenz,Regina Max,Matthias D. Becker +7 more
TL;DR: The largest cohort to date of consecutive patients with inflammatory eye disease from a specialized uveitis center is described, showing the usefulness of an interdisciplinary approach, oriented on anatomic presentation.
Journal ArticleDOI
Reduced CD4+,CD25− T cell sensitivity to the suppressive function of CD4+,CD25high,CD127−/low regulatory T cells in patients with active systemic lupus erythematosus
Ram Kumar Venigalla,Theresa Tretter,Stefan Krienke,Regina Max,Volker Eckstein,Norbert Blank,Christoph Fiehn,Anthony D. Ho,Hanns-Martin Lorenz +8 more
TL;DR: This study is the first to show that impaired sensitivity of Tresp cells to the suppressive effects of a comparably functional, highly purified nTreg cell population leads to a defective suppression of T cell proliferation in active SLE.
Journal ArticleDOI
Immunohistochemical analysis of integrin αvβ3 expression on tumor-associated vessels of human carcinomas
Regina Max,R.R.C.M. Gerritsen,P.T.G.A. Nooijen,Simon L. Goodman,Arne Sutter,U. Keilholz,Dirk J. Ruiter,R.M.W. de Waal +7 more
TL;DR: Taken together, the findings show a considerable number of colon, pancreas, lung and breast carcinoma lesions with many αvβ3‐expressing vessels that could be targets for anti‐αv β3‐therapy.
Journal ArticleDOI
Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma.
Carmen Scheibenbogen,Alexander Schmittel,Ulrich Keilholz,Thomas Allgäuer,Udo Hofmann,Regina Max,Eckhard Thiel,Dirk Schadendorf +7 more
TL;DR: Limited clinical and immunologic activity of HLA class 1-peptide vaccination in combination with granulocyte-macrophage colony-stimulating factor in stage IV melanoma patients is shown.
Journal ArticleDOI
QuantiFERON TB-Gold--a new test strengthening long-suspected tuberculous involvement in serpiginous-like choroiditis.
Friederike Mackensen,Matthias D. Becker,U. Wiehler,Regina Max,Alexander H. Dalpke,Stefan Zimmermann +5 more
TL;DR: QuantiFERON testing revealed a high number of positive patients, which indicates a tuberculous etiology in this uveitis subset, and whether bacterial activity or secondary immunologic processes are causative remains a matter of speculation.